financetom
Business
financetom
/
Business
/
Sula Vineyards' own brand sales volumes cross 1 million cases mark in FY23
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sula Vineyards' own brand sales volumes cross 1 million cases mark in FY23
Apr 11, 2023 1:53 PM

Leading wine producer Sula Vineyards Ltd on Tuesday said sales volume from its own brands crossed 1 million cases in FY23. Besides, sales volumes in elite & premium wines went past the 5 lakh cases mark for the first time, it said in a sales update for Q4 and FY23 submitted to the bourses.

Share Market Live

NSE

"The company has recorded its highest ever annual revenues both for its own brands as well as the wine tourism business," the company said.

On a provisional basis, Sula Vineyards said its net revenue for the March quarter was at Rs 104.3 crore from its own brands and Rs 12.4 crore from wine tourism, which represents room revenue, sale of food & beverages, merchandise, and all other ancillary services.

Also Read: Rico Vineyard and Winery tour For Bangaloreans: A perfect blend of wine, nature, and adventure for the weekend

For the financial year 2022-23, net revenue from own brands was at Rs 482.5 crore and Rs 45 crore from wine tourism.

"FY23 has been one of the most momentous and successful years in Sula’s 23-year journey. Our focus on premiumisation is reaping rich dividends – more than 52 per cent of 1 million cases are our elite & premium wines, including our Sula Vineyards, RASA & The Source brands. That share was just 46 percent in pre-pandemic FY19," the company’s CEO Rajeev Samant said.

About wine tourism, he said this business continues to soar and expect it to be a Rs 100 crore business in the coming year.

Sula has pioneered wine tourism in India and more than 3 lakh people visit Sula’s Nasik estate annually.

Also Read: DGHS urges doctors to avoid alcohol at seminars and conferences to set an example

First Published:Apr 11, 2023 10:53 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Carter’s, Inc. Announces Closing of Sale of $575 Million 7.375% Senior Notes Due 2031
Carter’s, Inc. Announces Closing of Sale of $575 Million 7.375% Senior Notes Due 2031
Nov 13, 2025
ATLANTA--(BUSINESS WIRE)-- Carter’s, Inc. (“Carter’s”) today announced that its wholly-owned subsidiary, The William Carter Company (the “Company”), has closed its previously announced sale of $575 million aggregate principal amount of 7.375% senior notes due 2031 (the “notes”). The Company received net proceeds from the offering of approximately $567 million, after deducting related fees and expenses, which it intends to use,...
Biomaterials maker Origin Q3 revenue falls on reduction in the supply chain activation program
Biomaterials maker Origin Q3 revenue falls on reduction in the supply chain activation program
Nov 13, 2025
Overview * Origin Materials ( ORGN ) Q3 revenue fell to $4.7 mln, down from $8.2 mln last year * Company secures convertible debt financing up to $90 mln to fund growth * Origin announces $20 mln equipment financing, increasing CapFormer capacity Outlook * Origin Materials ( ORGN ) maintains 2026 revenue guidance of $20 mln to $30 mln *...
Trevi Therapeutics Q3 Loss Narrows
Trevi Therapeutics Q3 Loss Narrows
Nov 13, 2025
04:17 PM EST, 11/13/2025 (MT Newswires) -- Trevi Therapeutics ( TRVI ) reported a Q3 loss late Thursday of $0.08 per diluted share, narrowing from the loss of $0.13 a year earlier. Analysts polled by FactSet expected a loss of $0.10. The company ended the quarter with $194.9 million in cash, cash equivalents and marketable securities, providing a cash runway...
Jefferson Capital Q3 Revenue Rises; Quarterly Dividend Maintained
Jefferson Capital Q3 Revenue Rises; Quarterly Dividend Maintained
Nov 13, 2025
04:16 PM EST, 11/13/2025 (MT Newswires) -- Jefferson Capital ( JCAP ) reported Q3 adjusted earnings late Thursday of $0.74 per share. The company did not provide a year-ago figure for comparison. Analysts polled by FactSet expected $0.64. Total revenue for the quarter ended Sept. 30 was $150.8 million, up from $110.6 million a year earlier. Analysts surveyed by FactSet...
Copyright 2023-2026 - www.financetom.com All Rights Reserved